Symbol | Exchange | Currency |
|---|
Investing.com – U.S. stocks were lower after the close on Thursday, as losses in the Consumer Services, Basic Materials and Technology sectors led shares lower. At the close in...
Investing.com – U.S. stocks were lower after the close on Wednesday, as losses in the Financials, Technology and Consumer Goods sectors led shares lower. At the close in NYSE, the...
Investing.com – U.S. stocks were mixed after the close on Tuesday, as gains in the Oil & Gas, Financials and Basic Materials sectors led shares higher while losses in the...
Stocks appear to be pausing as rates start to rise. Before the U.S. markets opened, short-term U.S. Treasury yields were rising. The five-year yields rose to their highest levels...
Valneva SE, a specialty vaccine company, focused on the development and commercialization of prophylactic vaccines for infectious diseases with unmet needs. Its commercial vaccines for travelers include IXIARO, an inactivated Vero cell culture-derived Japanese encephalitis vaccine indicated for active immunization against Japanese encephalitis; and DUKORAL, an oral vaccine for the prevention of diarrhea caused by Vibrio cholera and/or heat-labile toxin producing Enterotoxigenic Escherichia coli bacterium. The company also develops VLA15, a vaccine candidate that is in Phase II clinical trial against Borrelia; VLA1553, a vaccine candidate, which is in Phase III clinical trial against the chikungunya virus; and VLA2001, a vaccine candidate that has completed Phase I/II clinical trial against SARS-CoV-2. It sells its products in the United States, Canada, Germany, Austria, Nordics, the United Kingdom, other European countries, and internationally. The company has collaborations with Pfizer to co-develop and commercialize its Lyme disease vaccine; and Instituto Butantan for the development, manufacturing, and marketing of single-shot chikungunya vaccine. Valneva SE was incorporated in 1999 and is headquartered in Saint-Herblain, France.
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Sell | Sell | Strong Sell | Strong Sell | Buy |
| Technical Indicators | Sell | Strong Sell | Strong Sell | Strong Sell | Buy |
| Summary | Sell | Strong Sell | Strong Sell | Strong Sell | Buy |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 161.62 | 162.30 | 154.70 | -0.79 | -0.49% | 160.93M | NASDAQ | |||
| 308.71 | 309.53 | 289.01 | +5.54 | +1.83% | 37.96M | NASDAQ | |||
| 2,616.08 | 2,624.06 | 2,490.00 | +9.05 | +0.35% | 3.81M | NASDAQ | |||
| 474.43 | 475.32 | 432.09 | +11.65 | +2.52% | 1.08M | NASDAQ | |||
| 19.37 | 19.41 | 18.81 | +0.03 | +0.16% | 23.37M | NYSE | |||
| 930.00 | 933.51 | 851.47 | -13.90 | -1.47% | 50.28M | NASDAQ | |||
| 149.05 | 154.99 | 143.22 | -7.79 | -4.97% | 6.51M | NASDAQ | |||
| 128.45 | 128.51 | 122.39 | +2.17 | +1.72% | 576.95K | NYSE | |||
| 42.72 | 42.87 | 39.12 | +2.92 | +7.34% | 1.02M | NYSE | |||
| 51.87 | 52.16 | 49.09 | +1.23 | +2.43% | 525.25K | NYSE | |||
| 26.25 | 26.60 | 25.27 | -0.82 | -3.03% | 12.61M | NYSE | |||
| 10.42 | 10.73 | 9.82 | -0.57 | -5.19% | 9.66M | NYSE | |||
| 128.82 | 129.15 | 124.19 | -0.53 | -0.41% | 11.59M | NYSE | |||
| 50.29 | 50.65 | 48.65 | -0.60 | -1.18% | 2.68M | NYSE | |||
| 0.2057 | 0.00 | 0.00 | -0.0128 | -5.86% | 2.55M | NYSE |